TABLE 1.

Clinical information of patients used for PDOTS establishment

Patient ID	Age	Sex	Tumor	Cell type	MSI status	Stage	PDOTS
CRC1	63	F	Ascending colon	WD	MSS	1	O
CRC2	54	F	Hepatic flexure colon	MD	MSS	1	O
CRC3	76	M	Rectosigmoid junction	Mucinous	MSS	3	X
CRC4	74	F	Sigmoid colon	Mucinous	MSI‐H	3	O
CRC5	53	M	Rectum	WD	MSS	3	O
CRC6	60	M	Ascending colon	PD	MSI‐H	2	O
CRC7	28	F	Rectosigmoid junction	MD	MSS	3	O
CRC8	53	F	Ascending colon	MD	MSS	2	O
CRC9	49	M	Sigmoid colon	WD	MSS	1	X
CRC10	61	M	Sigmoid colon	WD	MSS	2	O
CRC11	79	F	Ascending colon	WD	MSS	3	O
CRC12	53	F	Rectosigmoid junction	MD	MSS	3	O
CRC13	54	M	Upper rectum	MD	MSI‐H	2	O
CRC14	68	M	Ascending colon	MD	MSI‐L	3	O
CRC15	51	M	Splenic flexure colon	Mucinous	MSS	2	O

Abbreviations: MD, moderately differentiated; MSI‐H, microsatellite instability‐high; MSI‐L, microsatellite instability‐low; MSS, microsatellite stable; O, success to establish organoids; PD, poorly differentiated; X, fail to establish organoids; WD, well differentiated.